Cargando…
Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study
Patients with vasospastic angina (VSA) who are resuscitated from sudden cardiac arrest (SCA) are at a high risk of recurrent lethal arrhythmia and cardiovascular events. However, the benefit of the implantable cardioverter-defibrillator (ICD) therapy in this population has not been fully elucidated....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621437/ https://www.ncbi.nlm.nih.gov/pubmed/36315563 http://dx.doi.org/10.1371/journal.pone.0277034 |
_version_ | 1784821554138316800 |
---|---|
author | Tateishi, Kazuya Kondo, Yusuke Saito, Yuichi Kitahara, Hideki Fukushima, Kenichi Takahashi, Hidehisa Yamashita, Daichi Ohashi, Koichi Suzuki, Ko Hashimoto, Osamu Sakai, Yoshiaki Kobayashi, Yoshio |
author_facet | Tateishi, Kazuya Kondo, Yusuke Saito, Yuichi Kitahara, Hideki Fukushima, Kenichi Takahashi, Hidehisa Yamashita, Daichi Ohashi, Koichi Suzuki, Ko Hashimoto, Osamu Sakai, Yoshiaki Kobayashi, Yoshio |
author_sort | Tateishi, Kazuya |
collection | PubMed |
description | Patients with vasospastic angina (VSA) who are resuscitated from sudden cardiac arrest (SCA) are at a high risk of recurrent lethal arrhythmia and cardiovascular events. However, the benefit of the implantable cardioverter-defibrillator (ICD) therapy in this population has not been fully elucidated. The present study aimed to analyze the prognostic impact of ICD therapy on patients with VSA and SCA. A total of 280 patients who were resuscitated from SCA and received an ICD for secondary prophylaxis were included in the present multicenter registry. The patients were divided into two groups on the basis of the presence of VSA. The primary endpoint was a composite of all-cause death and appropriate ICD therapy (appropriate anti-tachycardia pacing and shock) for recurrent ventricular arrhythmias. Of 280 patients, 51 (18%) had VSA. Among those without VSA, ischemic cardiomyopathy was the main cause of SCA (38%), followed by non-ischemic cardiomyopathies (18%) and Brugada syndrome (7%). Twenty-three (8%) patients were dead and 72 (26%) received appropriate ICD therapy during a median follow-up period of 3.8 years. There was no significant difference in the incidence of the primary endpoint between patients with and without VSA (24% vs. 33%, p = 0.19). In a cohort of patients who received an ICD for secondary prophylaxis, long-term clinical outcomes were not different between those with VSA and those with other cardiac diseases after SCA, suggesting ICD therapy may be considered in patients with VSA and those with other etiologies who were resuscitated from SCA. |
format | Online Article Text |
id | pubmed-9621437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-96214372022-11-01 Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study Tateishi, Kazuya Kondo, Yusuke Saito, Yuichi Kitahara, Hideki Fukushima, Kenichi Takahashi, Hidehisa Yamashita, Daichi Ohashi, Koichi Suzuki, Ko Hashimoto, Osamu Sakai, Yoshiaki Kobayashi, Yoshio PLoS One Research Article Patients with vasospastic angina (VSA) who are resuscitated from sudden cardiac arrest (SCA) are at a high risk of recurrent lethal arrhythmia and cardiovascular events. However, the benefit of the implantable cardioverter-defibrillator (ICD) therapy in this population has not been fully elucidated. The present study aimed to analyze the prognostic impact of ICD therapy on patients with VSA and SCA. A total of 280 patients who were resuscitated from SCA and received an ICD for secondary prophylaxis were included in the present multicenter registry. The patients were divided into two groups on the basis of the presence of VSA. The primary endpoint was a composite of all-cause death and appropriate ICD therapy (appropriate anti-tachycardia pacing and shock) for recurrent ventricular arrhythmias. Of 280 patients, 51 (18%) had VSA. Among those without VSA, ischemic cardiomyopathy was the main cause of SCA (38%), followed by non-ischemic cardiomyopathies (18%) and Brugada syndrome (7%). Twenty-three (8%) patients were dead and 72 (26%) received appropriate ICD therapy during a median follow-up period of 3.8 years. There was no significant difference in the incidence of the primary endpoint between patients with and without VSA (24% vs. 33%, p = 0.19). In a cohort of patients who received an ICD for secondary prophylaxis, long-term clinical outcomes were not different between those with VSA and those with other cardiac diseases after SCA, suggesting ICD therapy may be considered in patients with VSA and those with other etiologies who were resuscitated from SCA. Public Library of Science 2022-10-31 /pmc/articles/PMC9621437/ /pubmed/36315563 http://dx.doi.org/10.1371/journal.pone.0277034 Text en © 2022 Tateishi et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Tateishi, Kazuya Kondo, Yusuke Saito, Yuichi Kitahara, Hideki Fukushima, Kenichi Takahashi, Hidehisa Yamashita, Daichi Ohashi, Koichi Suzuki, Ko Hashimoto, Osamu Sakai, Yoshiaki Kobayashi, Yoshio Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study |
title | Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study |
title_full | Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study |
title_fullStr | Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study |
title_full_unstemmed | Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study |
title_short | Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study |
title_sort | implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: a retrospective study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621437/ https://www.ncbi.nlm.nih.gov/pubmed/36315563 http://dx.doi.org/10.1371/journal.pone.0277034 |
work_keys_str_mv | AT tateishikazuya implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT kondoyusuke implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT saitoyuichi implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT kitaharahideki implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT fukushimakenichi implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT takahashihidehisa implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT yamashitadaichi implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT ohashikoichi implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT suzukiko implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT hashimotoosamu implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT sakaiyoshiaki implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy AT kobayashiyoshio implantablecardioverterdefibrillatortherapyafterresuscitationfromcardiacarrestinvasospasticanginaaretrospectivestudy |